Gabapentin Capsule
Product Images NDC 68788-7848

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-7848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Capsules 300mg (civ)

Gabapentin Capsules 300 mg (CV) packaging label from Preferred Pharmaceuticals, Inc. The label states the product is generic for Neurontin, with each capsule containing 300 mg of gabapentin. It includes spaces for package size, expiration date, lot, batch, and insurance information. The manufacturer is listed as ScieGen Pharmaceuticals, Inc. The label features a yellow area with directions for use in English and Spanish, instructing to take capsules every specified number of hours. A barcode and a caution about federal law restricting drug transfer are also present.*

FDA Label Image

Figure 1 (Image 01)

A line graph depicting mean pain score over eight weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores ranging from 0 to 10. Two distinct periods are indicated: a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing trend in mean pain score, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

Line graph showing mean pain score over 7 weeks for placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups. The x-axis represents weeks divided into a 3-week dose titration period and a 4-week fixed dose period, and the y-axis is the mean pain score decreasing over time for Gabapentin groups compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing comparison between placebo (PBO) and Gabapentin (GBP) at different dosages in two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

Formula showing the calculation for creatinine clearance (CLCr) based on age, weight, serum creatinine, and adjustment factor for female patients. The image illustrates the variables used in determining creatinine clearance in clinical settings.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing a cyclohexane ring bonded to an aminomethyl group and an acetic acid group, illustrating the molecule's arrangement for the 300 mg capsule formulation by Preferred Pharmaceuticals, Inc.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

A scatter plot graph showing percentage difference on the y-axis versus daily dose in milligrams on the x-axis, with data points representing three different studies labeled as Study a, Study b, and Study c. Each study is represented by a different colored square marker, depicting dose-response differences at doses approximately 600 mg, 900 mg, 1200 mg, and 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.